U-Blot® Research Grade Ladiratuzumab

U-Blot® Research Grade Ladiratuzumab
U-Blot® Research Grade Ladiratuzumab
$9,999.00
Size:50ug
SKU: WA3035-50

Catalog No.: WA3035

Specification: 50ug/100ug

Stock: In stock

Product details, specifications, documents, and related products are available from the catalog record. Learn more

10.19产品详情通用banner:Join us at JSI 2026 to explore the future of immunology! See you in Osaka!data:11.20;local:xxxxxxxxxxxxxx
Learn more

Product information

Product details, specifications, documents, and related products are available from the catalog record.

Product Overview

Catalog No.
WA3035
SKU
WA3035-50
Category
Biosimilar Antibodies
Product Type
Other
Size
50ug/100ug
Stock Status
In stock
Available Stock
999
Minimum Order Quantity
1

Storage & Compliance

Storage
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C for short-term storage (1-2 weeks). Store at -20°C for up to 12 months. For long-term storage, store at -80°C.
Research Use Only
Yes

Additional Specifications

PackSize
50ug/100ug
Target
SLC39A6
Reactivity
Human
Applications
ELISA, Bioactivity: FACS, Functional assay, Research in vivo
Host Species
Humanized
Isotype
IgG1-kappa
Conjugate/Modification
--
Recommended Dilution Ratio
--
Composition
0.01M PBS, pH 7.4.
Purification Process
Protein A/G purified from cell culture supernatant.
Purity
>95% purity as determined by SDS-PAGE.
storageCondition
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C for short-term storage (1-2 weeks). Store at -20°C for up to 12 months. For long-term storage, store at -80°C.
Clonality
Monoclonal
Clone Number
--
Immunogen
Mammalian Cells
Alias
SLC39A6, LIV1, Zrt- and Irt-like protein 6, Zinc transporter ZIP6, ZIP-6, Estrogen-regulated protein LIV-1, Solute carrier family 39 member 6, ZIP6
Species
--
Gene ID-1
Q13433
Uniprot
--
Background
Ladiratuzumab (hLIV22) is an anti-LIV-1/ZIP6 humanized monoclonal antibody. Ladiratuzumab, conjugated with the microtubule disrupting agent, MMAE to compose SGN-LIV1A, an antibody-drug conjugate (ADC). Ladiratuzumab can be used for research of breast cancer.<br>• Zinc and cancer: implications for LIV-1 in breast cancer., PMID:22852056<br/>• Recombinant Expression of Zinc Transporter SLC39A6 and Its Functional Antibody Production., PMID:31009334<br/>• Zip6 (LIV-1) regulates zinc uptake in neuroblastoma cells under resting but not depolarizing conditions., PMID:18272141<br/>• A mechanism for epithelial-mesenchymal transition and anoikis resistance in breast cancer triggered by zinc channel ZIP6 and STAT3 (signal transducer and activator of transcription 3)., PMID:23919497<br/>• Concordant correlation of LIV-1 and E-cadherin expression in human breast cancer cell MCF-7., PMID:18330719<br/>• Zip6-attenuation promotes epithelial-to-mesenchymal transition in ductal breast tumor (T47D) cells., PMID:19852955<br/>• Microarray analyses of oral punch biopsies from acute myeloid leukemia (AML) patients treated with chemotherapy., PMID:21862359<br/>
Tissue Expression
--
Signaling_pathway
--
Research Areas
--

Tech Support

ucallm

01

Documents

Datasheet, COA, SDS, and protocol files can be requested from technical support.

02

Storage & Handling

Storage
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C for short-term storage (1-2 weeks). Store at -20°C for up to 12 months. For long-term storage, store at -80°C.
06

Contact Support

Emailinfo@mail.ucallm.com

Phone+(1)-866-986-9598

WeChat / IMUcallm-Tech

HoursMonday-Friday 09:00-18:00 CST

Request Technical Support
Keywords:Biosimilar Antibodies